Median Technologies Share Price

Equities

ALMDT

FR0011049824

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 16:35:27 12/07/2024 BST 5-day change 1st Jan Change
2.37 EUR -2.47% Intraday chart for Median Technologies -12.22% -50.11%

Financials

Sales 2024 * 23.89M 26.05M 2.01B Sales 2025 * 29.72M 32.42M 2.5B Capitalization 43.6M 47.54M 3.66B
Net income 2024 * -24M -26.17M -2.02B Net income 2025 * -21M -22.9M -1.76B EV / Sales 2024 * 2.63 x
Net Debt 2024 * 19.22M 20.97M 1.62B Net Debt 2025 * 39.22M 42.77M 3.29B EV / Sales 2025 * 2.79 x
P/E ratio 2024 *
-1.73 x
P/E ratio 2025 *
-1.92 x
Employees 256
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.47%
1 week-12.22%
Current month-10.40%
1 month-21.00%
3 months-38.76%
6 months-45.89%
Current year-50.11%
More quotes
1 week
2.33
Extreme 2.33
2.85
1 month
2.33
Extreme 2.33
3.09
Current year
2.33
Extreme 2.325
5.06
1 year
2.33
Extreme 2.325
5.66
3 years
2.33
Extreme 2.325
18.32
5 years
0.93
Extreme 0.93
18.32
10 years
0.90
Extreme 0.9
18.32
More quotes
Managers TitleAgeSince
Founder 62 31/12/01
Director of Finance/CFO - 11/07/21
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 24/06/20
Chairman 62 25/03/08
Director/Board Member 67 29/11/15
More insiders
Date Price Change Volume
12/07/24 2.37 -2.47% 74,302
11/07/24 2.43 -6.54% 50,624
10/07/24 2.6 -3.35% 89,178
09/07/24 2.69 -3.58% 52,753
08/07/24 2.79 +3.33% 51,233

Real-time Euronext Paris, July 12, 2024 at 04:35 pm

More quotes
Median Technologies offers innovative imaging solutions and services to improve healthcare for all. The group uses the power of phenomic imaging to contribute to the emergence of new therapies and treatment strategies for patients. Its solutions, «iSee» for the image management in oncology trials and «eyonisTM» (formerly iBiopsy®), its phenomic imaging platform, combined with the expertise of its teams are an essential part to the discovery of new drugs and diagnostic tools to monitor diseases and evaluate the response of patients to their therapy. Median Technologies is helping biopharmaceutical companies and healthcare professionals quickly and accurately introduce new treatments to patients who need them, with a view to reducing overall costs of care. Provision of services accounts for all net sales. Net sales are distributed geographically as follows: China (41.6%), the United States and Canada (30.4%), Europe and other (28%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.37 EUR
Average target price
16.92 EUR
Spread / Average Target
+614.14%
Consensus

Annual profits - Rate of surprise